DHX9 (DEAH-Box Helicase 9), also known as RNA helicase A, is a nucleic acid helicase that unwinds both DNA and RNA substrates. It plays essential roles in transcription regulation, RNA processing, DNA damage response, and maintains genomic stability. Dysregulation of DHX9 has been implicated in cancer and neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS) [1][2].
| Attribute |
Value |
| Symbol |
DHX9 |
| Full Name |
DEAH-Box Helicase 9 |
| Aliases |
RNA helicase A, LBP, NDH2 |
| Chromosomal Location |
1q25.3 |
| NCBI Gene ID |
1660 |
| OMIM |
603115 |
| Ensembl ID |
ENSG00000135829 |
| UniProt ID |
Q9NQZ2 |
The DHX9 gene spans approximately 50 kb on chromosome 1q25.3 and consists of multiple exons. The gene encodes a protein of approximately 1,090 amino acids with a molecular weight of 140 kDa.
¶ Protein Domains
DHX9 contains several functional domains:
- N-terminal region: DNA-binding domain
- DEAH box: ATP-dependent helicase core domain
- C-terminal: RNA-binding domains (dsRBDs)
DHX9 is a multifunctional helicase with unique substrate specificity:
- DNA/RNA hybrid unwinding: Unwinds DNA-RNA hybrids (R-loops)
- G-quadruplex unwinding: Resolves G-quadruplex structures in DNA and RNA
- Double-stranded RNA unwinding: Catalyzes ATP-dependent unwinding of dsRNA
DHX9 acts as a transcriptional coactivator:
- RNA polymerase II regulation: Positive regulation of transcription by RNA polymerase II
- Chromatin binding: Binds to promoter-specific chromatin regions
- Transcription factor interaction: Interacts with RNA polymerase II-specific transcription factors
DHX9 participates in multiple RNA processing pathways:
- Alternative splicing: Involved in spliceosome function and alternative mRNA splicing
- mRNA transport: Facilitates mRNA processing and transport
- mRNA stability: CRD-mediated mRNA stabilization
- miRNA function: Involved in RISC complex assembly and miRNA-mediated gene silencing
R-loops are three-stranded nucleic acid structures that can cause genomic instability when not properly resolved. DHX9 plays a critical role in R-loop management:
- ATR phosphorylation: Upon genotoxic stress, ATR phosphorylates DHX9 at serine 321
- R-loop suppression: Phosphorylated DHX9 suppresses R-loop accumulation
- Replication stress mitigation: DHX9-AKT1 interaction mitigates R-loop-induced replication stress
DHX9 supports DNA repair pathways:
- Positive regulation of DNA repair: Promotes repair of DNA damage
- DNA replication support: Facilitates DNA replication under stress conditions
DHX9 has been implicated in ALS pathogenesis through several mechanisms:
- Protein aggregation: DHX9 aggregates in motor neurons of ALS patients
- R-loop dysregulation: Impaired R-loop resolution contributes to genomic instability
- RNA metabolism defects: Disrupted RNA processing affects motor neuron survival
DHX9 dysregulation is connected to:
- Genomic instability: Accumulation of DNA damage in neurons
- Transcription defects: Impaired gene expression regulation
- RNA toxicity: Aberrant RNA processing and R-loop formation
| Partner |
Interaction Type |
Functional Outcome |
| ATR |
Phosphorylation |
R-loop suppression under genotoxic stress |
| AKT1 |
Physical interaction |
Replication stress mitigation |
| RNA Pol II |
Transcription coactivator |
Gene expression regulation |
| Spliceosome |
Component |
Alternative splicing |
| RISC complex |
Component |
miRNA function |
| Strategy |
Description |
Status |
| Helicase modulators |
Small molecules targeting DHX9 helicase activity |
Research |
| R-loop stabilizers |
Prevent excessive R-loop accumulation |
Research |
| ATR inhibitors |
Indirectly affect DHX9 phosphorylation |
Preclinical |
- Understanding R-loop biology: How dysregulated R-loops contribute to neurodegeneration
- Therapeutic modulation: Developing strategies to enhance DHX9 function
- Biomarker development: DHX9 as a potential biomarker for neurodegenerative diseases
DHX9 activity and phosphorylation status may serve as:
- Diagnostic markers: For ALS and related neurodegenerative conditions
- Prognostic indicators: Disease progression markers
- Therapeutic targets: For drug development
- Mechanism elucidation: Complete understanding of DHX9's role in neurodegeneration
- Therapeutic development: Small molecule modulators of DHX9
- Model systems: Development of relevant cellular and animal models